Patents matching “Nektar Therapeutics”

US 7419600

Method for purifying a branched water-soluble polymer

Nektar Therapeutics AL, Corporation · Granted Sep 2, 2008 · Expires Aug 28, 2028

US 7405266

Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof

Nektar Therapeutics AL, Corporation · Granted Jul 29, 2008 · Expires Jul 24, 2028

US 7393544

Dispersion for pulmonary delivery of a bioactive agent

Nektar Therapeutics · Granted Jul 1, 2008 · Expires Jun 26, 2028

US 7378469

Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol)

Nektar Therapeutics AL, Corporation · Granted May 27, 2008 · Expires May 22, 2028

US 7368102

Pulmonary delivery of aminoglycosides

Nektar Therapeutics · Granted May 6, 2008 · Expires May 1, 2028

US 7329721

Maleamic acid polymer derivatives and their bioconjugates

Nektar Therapeutics AL, Corporation · Granted Feb 12, 2008 · Expires Feb 7, 2028

US 7326691

Compositions comprising amphotericin B, methods, and systems

Nektar Therapeutics · Granted Feb 5, 2008 · Expires Jan 31, 2028

US 7316811

Multi-arm polypeptide-poly (ethylene glycol) block copolymers as drug delivery vehicles

Nektar Therapeutics AL, Corporation · Granted Jan 8, 2008 · Expires Jan 3, 2028

US 7312301

Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof

Nektar Therapeutics AL, Corporation · Granted Dec 25, 2007 · Expires Dec 20, 2027

US 7306787

Engineered particles and methods of use

Nektar Therapeutics · Granted Dec 11, 2007 · Expires Dec 6, 2027

US 7300919

Pulmonary delivery of active fragments of parathyroid hormone

Nektar Therapeutics · Granted Nov 27, 2007 · Expires Nov 22, 2027

US 7265186

Multi-arm block copolymers as drug delivery vehicles

Nektar Therapeutics AL, Corporation · Granted Sep 4, 2007 · Expires Aug 30, 2027

US 7223803

Polyethylene (glycol) derivatives with proximal reactive groups

Nektar Therapeutics AL, Corporation · Granted May 29, 2007 · Expires May 24, 2027

US 7214366

Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules

Nektar Therapeutics AL, Corporation · Granted May 8, 2007 · Expires May 3, 2027

US 7208145

Polymeric reagents comprising a ketone or a related functional group

Nektar Therapeutics AL, Corporation · Granted Apr 24, 2007 · Expires Apr 19, 2027

US 7205380

Sterically hindered poly (ethylene glycol) alkanoic acids and derivatives thereof

Nektar Therapeutics AL, Corporation · Granted Apr 17, 2007 · Expires Apr 12, 2027

US 7199223

Polymer-factor VIII moiety conjugates

Nektar Therapeutics AL, Corporation · Granted Apr 3, 2007 · Expires Mar 29, 2027

US 7172768

Storage stable powder compositions of interleukin-4 receptor

Nektar Therapeutics · Granted Feb 6, 2007 · Expires Feb 1, 2027

US 7157546

Water-soluble polymer alkanals

Nektar Therapeutics AL, Corporation · Granted Jan 2, 2007 · Expires Dec 28, 2026

US 7150766

Method of particle formation

Nektar Therapeutics UK, Ltd · Granted Dec 19, 2006 · Expires Dec 14, 2026

US 7141236

Methods and compositions for delivering macromolecules to or via the respiratory tract

Nektar Therapeutics · Granted Nov 28, 2006 · Expires Nov 23, 2026

US 7138141

Dispersible macromolecule compositions and methods for their preparation and use

Nektar Therapeutics · Granted Nov 21, 2006 · Expires Nov 16, 2026

US 7115280

Particle formation methods and their products

Nektar Therapeutics UK, Ltd · Granted Oct 3, 2006 · Expires Sep 28, 2026

US 7112341

Pulmonary administration of dry powder formulations for treating infertility

Nektar Therapeutics · Granted Sep 26, 2006 · Expires Sep 21, 2026